Synthesis of new pyrido[4,3-g and 3,4-g]quinoline-
Introduction
The quinone nucleus is an important structural moiety in a number of complex chemotherapeutic agents target the DNA, playing an important role in determining their biological activities. Doxorubicin and mitoxantrone are representative of this class and are widely used in the treatment of several leukaemia and lymphomas as well as in combination chemotherapy of solid tumors. 1 The importance of this class of antitumour agents has stimulated a number of studies, aimed to developing new agents that retain the core quinonic moiety yet exhibit different spectra of potency, together with reduced overall toxicity. 2 In this sense, the introduction of heteroatom (N, order to increase their therapeutic index. [3] [4] [5] These bioisosteres retain the planarity, spatial, and electronic characteristics required for molecular recognition at the cellular level and would clearly differ from their carbocyclic counterparts in their interaction with specific targets as well as in their reduction potential.
In this sense, we have recently reported a versatile method directed towards the synthesis of new cyclic quinone derivatives (Figure 1 ), that is, the benzo[g]isoquinoline-5,10-dione (I) and the dihydrothieno [2,3-b] naphtho-4,9-dione (II, DTNQ) derivatives which have presented evidence for their in vitro antitumour activity. In order to extend the synthetic scope of this method, we planned to synthesize new pyrido [4,3- g and 3,4-g]quinoline-5,10-dione and dihydrothiopheno[2,3-g and 3,2-g]quinoline-4,9-dione derivatives (DTQQ) considered as I and II aza analogues. These compounds and several acyl-DTQQ derivatives were evaluated in vitro for their cytotoxic activity against MT-4 cell line.
Results and Discussion
The compounds presented in this study were obtained by a cycloaddition reaction between the corresponding thiazolidine derivatives 1a-e and quinoline-5,8-dione, using silver carbonate and DBU as base, following the method that we previously described 6 (Scheme 1).
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After acid hydrolysis and classic work-up, the corresponding pyrido[4,3-g]quinoline-5,10-dione (2a-e) and pyrido [3,4- g]quinoline-5,10-dione (3a-e) derivatives were obtained as regioisomeric mixture in different ratios (1-1.3:1), with yields varying from 20-45%. The regioisomeric mixtures 2c/3c and 2d/3d were chromatographically resolved whilst the compounds 2a/3a, 2b/3b and 2e/3e were purified and tested as mixture of regioisomers. The 1 H NMR analysis of the 2 and 3 derivatives showed differences in the chemical shifts of 4-H and 6 or 9-H protons between the two regioisomers. The 4-H proton of regioisomers 2 was observed low field shifted of 0.11-0.25 ppm compared to corresponding signal for the compounds 3. On the other hand, the 6-H proton of regioisomers 2 was high shifted of 0.12 ppm respect to 9-H of the compounds 3. Proof of structures were made by 2D 1 H 13 C NMR HMBC correlation performed on 2d and 3d. (Figure 2 In these experiments, long-range correlations were observed between the following protons and carbons of 2d: H-4/C-2, H-4/C-5, H-6/C-5, and H-6/CO ester, while the opposite regioisomer 3d gave 3 J coupling between H-4/C-2, H-4/C-5, H-9/C-10, and H-9/CO ester, so that the connectivities of the quaternary carbons (4a, 5a, 9a, and 10a) in 2 and 3 were clarified. On the other hand, the dihydrothieno[2,3-g and 3,2-g]quinoline-4,9-dione derivatives (DTQQs, 4 and 5) were obtained as 2.2:1 regioisomeric mixture with yields varying from 15-40%, and separated chromatographically. The regiochemistry of compounds 4 and 5 have been assigned by reference to theoretical considerations and by analogy with the work of different authors. 8 Thus, the formation of major compound 4 may be attributed to the electronwithdrawing effect of the quinoline nitrogen atom making the C-8 carbonyl group more electron deficient, with preferential attack of the sulphur at the C-6 position. A series of acyl DTQQs derivatives containing different aromatic moiety, were prepared by coupling of 4 and 5 with both 2-iodo (6 and 7) and 3-fluorobenzoyl chloride (8 and 9) using TEA as base, and Boc-L-Phe amino acid using HBTU/HOBt as coupling agents. After Boc-deprotection, the compounds 10 and 11 were obtained as HCl salts. Subsequently, reaction of these compounds with phenylisothiocyanate gave the N-carbamoyl derivatives 12 and 13, respectively. The structures of all compounds were confirmed from their analytical and spectroscopic data. In this preliminary study, the compounds were tested in vitro for the grow inhibition of MT-4 cell lines, as monitored by the MTT method, 9, 10 and the results are reported in Tables 1 and 2 .
For comparative purposes, we evaluated the cytotoxic activities of compounds relative to doxorubicine. As shown in Table 1 , the regioisomer mixtures 2,3-b and 2,3-e and the compounds 2c, 3c, and 3d exhibited similar activity against of MT-4 cell line at µM range. Only the compounds supporting a chloride atom at position 4 of phenyl ring showed certain specificity in the interaction with the target. In fact, the compound 3d showed to be 18 times more active compared to the regioisomers 2d. However, more encouraging results were obtained by the DTQQ derivatives. In fact, the regioisomers 4 and 5 showed similar activity at submicromolar concentration (Table 2 ) and were 4 time more potent that the carbocyclic analogue, (DTNQ, CC 50 = 1.2 µM). 7 The incorporation in DTQQs of 2-iodo or 3-fluorobenzoyl residues (6-9) conserved practically the activity in the same range, whereas the incorporation of Phe residues (10, 11) significantly reduced the cytotoxicity by 10 and 100 fold, respectively. This activity was recovered with derivatives supporting of phenylthio carbamoyl moiety (12, 13). Although the compounds here reported are less active compared to doxorubicine, the dihydrothieno[2,3-g and 3,2-g]quinoline-4,9-dione (DTQQ) derivatives represent a potential starting point in discovering of new antitumoral agents. In particular, the synthetic method developed to produce these compounds could be used to perform libraries by combinatorial approach to optimize the activity of the DTQQ derivatives. In fact, the results obtained indicate that it is possible to design analogues that could be more effective on tumoral cells by introducing of appropriate structural modifications on dihydrothiophene ring.
In conclusion, we report the synthesis and in vitro biological evaluation of new quinone derivatives as potential cytotoxic agents. The first results confirm the validity of our synthetic method providing practical access to quinone-based derivatives of intense current interest in antitumoral therapy. Further experiments aimed at defining the target and the mechanisms of the inhibitory effect showed by these molecules are in progress and the results will be reported in a forthcoming paper. Reagents, starting material and solvents were purchased from commercial suppliers and used as received. Analytical TLC was performed on a 0.25 mm layer of silica gel 60 F 254 Merck and silica gel 60 (300-400 mesh), Merck, was used for flash chromatography. Melting points were taken on a Kofler apparatus and are uncorrected.
1 H NMR and 13 C NMR spectra were recorded with a Bruker-500 spectrometer, operating at 500 and 125 MHz respectively. Chemical shifts are reported in δ values (ppm) relative to internal Me 4 Si and J values are reported in Herz (Hz) . Mass spectra were obtained using a FAB-MS spectrometer. IR spectra were measured on a Nicolet Avatar 360 FT-IR; values are expressed in wavenumbers (cm -1 ).
The ethyl 2(S,R)-(aryl)-1,3-thiazolidine-4(S)-carboxylate derivatives 1a-e and the quinoline-5,8-dione were prepared following the procedure reported in literature, 11, 12 and were used directly in the next step without further purification.
Chemistry
General procedure for the synthesis of compounds 2a-e/3a-e, 4 and 5 According to the procedure previously described 6 the corresponding thiazolidine (compounds 1a-e) (1-3 mmol) was dissolved in dry acetonitrile (20-50 mL) and quinoline-5,8-dione (2 eq.), silver carbonate (1 eq. respect to thiazolidine) and a solution of DBU (0.2 eq respect to thiazolidine) in acetonitrile were added. After 12 h at room temperature, diethyl ether was added, the mixture was filtered and the solvent was evaporated. The reaction mixture was dissolved in chloroform and treated with 1N HCl solution (20-30 mL) for 1 h. Then, chloroform and water were added, the organic phase was washed with 1N HCl (2 x 25 mL), water (2 x 25 mL) and dried with anhydrous Na 2 SO 4 . Removal of the solvent and flash chromatography (FC) of the residues yielded the corresponding Diels-Alder adduct (compounds 2a-e and 3a-e). The collected acidic aqueous phases were neutralized with 10% NaHCO 3 solution and the free amines 4 and 5 (DTQQs) were extracted with chloroform (3 x 25 mL) and purified with FC using a gradient of 0-30% acetone in ethyl acetate. -8-ethoxycarbonylpyrido[3,4-g]quinoline-5,10-dione (2b and 3b) 
